CD274 and neoplasm: By evading PD-L1-mediated immune checkpoints, GENPs synergized with anti-PD-L1 therapy to reduce tumor recurrence and distant metastasis, highlighting their dual role as antigen carriers and immune checkpoint modulators (128).